Index
RUT
P/E
-
EPS (ttm)
-0.93
Insider Own
4.65%
Shs Outstand
49.85M
Perf Week
-5.43%
Market Cap
506.99M
Forward P/E
-
EPS next Y
-0.66
Insider Trans
-2.99%
Shs Float
47.54M
Perf Month
29.16%
Enterprise Value
368.77M
PEG
-
EPS next Q
-0.22
Inst Own
93.81%
Perf Quarter
-1.27%
Income
-46.65M
P/S
2.88
EPS this Y
-153.76%
Inst Trans
-1.45%
Perf Half Y
-6.13%
Sales
176.18M
P/B
1.09
EPS next Y
12.76%
ROA
-4.94%
Perf YTD
5.21%
Book/sh
9.23
P/C
1.23
EPS next 5Y
-
ROE
-8.02%
52W High
11.45 -11.79%
Perf Year
77.19%
Cash/sh
8.19
P/FCF
-
EPS past 3/5Y
-0.23% 13.68%
ROIC
-8.58%
52W Low
5.31 90.21%
Perf 3Y
-52.00%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-9.45% 17.49%
Gross Margin
39.99%
Volatility
4.43% 4.34%
Perf 5Y
-81.34%
Dividend TTM
-
EV/Sales
2.09
EPS Y/Y TTM
62.52%
Oper. Margin
-25.09%
ATR (14)
0.43
Perf 10Y
317.36%
Dividend Ex-Date
-
Quick Ratio
2.07
Sales Y/Y TTM
-22.86%
Profit Margin
-26.48%
RSI (14)
58.18
Dividend Gr. 3/5Y
- -
Current Ratio
2.17
EPS Q/Q
49.12%
SMA20
3.13%
Beta
1.76
Payout
-
Debt/Eq
0.46
Sales Q/Q
-23.65%
SMA50
14.08%
Rel Volume
1.00
Prev Close
10.38
Employees
738
LT Debt/Eq
0.08
SMA200
10.86%
Avg Volume
418.16K
Price
10.10
IPO
Jan 31, 2005
Option/Short
Yes / Yes
Trades
Volume
418,058
Change
-2.70%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-06-25 Upgrade
Leerink Partners
Market Perform → Outperform
$16
Aug-06-25 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
Jul-22-25 Resumed
Stephens
Overweight
$13
Mar-24-25 Upgrade
UBS
Neutral → Buy
$10
Dec-19-24 Initiated
Guggenheim
Buy
$11
Aug-07-24 Downgrade
Jefferies
Buy → Hold
$20 → $8
Jul-31-24 Upgrade
B. Riley Securities
Neutral → Buy
$19 → $15
May-03-24 Downgrade
B. Riley Securities
Buy → Neutral
$22 → $19
Apr-04-24 Resumed
Jefferies
Buy
$17 → $21
Mar-13-24 Reiterated
Needham
Buy
$19 → $18
Aug-17-23 Initiated
Morgan Stanley
Equal-Weight
$16
Aug-10-23 Downgrade
Stephens
Overweight → Equal-Weight
$15
Jul-18-23 Downgrade
UBS
Buy → Neutral
$28 → $17
Jul-17-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jul-13-23 Downgrade
SVB Securities
Outperform → Market Perform
$30 → $10
Jan-19-22 Upgrade
ROTH Capital
Neutral → Buy
$90
Nov-05-21 Downgrade
ROTH Capital
Buy → Neutral
$78 → $90
Oct-19-21 Resumed
B. Riley Securities
Buy
$81
Jul-16-21 Initiated
BTIG Research
Buy
$80
Mar-15-21 Initiated
UBS
Buy
$84
Show Previous Ratings
Apr-20-26 04:05PM
Mar-04-26 08:30AM
12:00AM
Mar-03-26 07:02PM
05:25PM
04:05PM
Loading…
04:05PM
Feb-18-26 08:10AM
Feb-17-26 08:00AM
Feb-11-26 08:30AM
08:16AM
Nov-05-25 12:09AM
Nov-04-25 05:50PM
04:05PM
Nov-03-25 08:01AM
Oct-30-25 08:30AM
08:00AM
Loading…
Oct-21-25 08:00AM
Oct-17-25 04:09AM
Oct-07-25 08:30AM
Oct-01-25 08:30AM
Aug-06-25 03:32AM
Aug-05-25 06:35PM
04:19PM
Aug-04-25 05:55PM
10:02AM
Jul-31-25 05:25PM
10:00AM
Jul-29-25 10:00AM
Jul-25-25 09:55AM
Jul-22-25 08:00AM
Jul-08-25 08:00AM
07:45AM
Loading…
07:45AM
Jul-04-25 12:00PM
Jun-27-25 12:00PM
Jun-12-25 08:00AM
May-28-25 09:55AM
May-12-25 09:55AM
May-08-25 03:34AM
May-07-25 07:15PM
07:15PM
05:20PM
04:05PM
May-06-25 09:35AM
Apr-30-25 10:01AM
Apr-24-25 08:30AM
Apr-10-25 10:39AM
Apr-04-25 06:03AM
Mar-31-25 03:11PM
09:06AM
08:09AM
Mar-26-25 09:15AM
Mar-18-25 07:59PM
Mar-13-25 07:28AM
Mar-12-25 08:30AM
Mar-05-25 02:10AM
Mar-04-25 05:35PM
04:10PM
Mar-03-25 07:18AM
Feb-18-25 08:30AM
Jan-21-25 08:30AM
Jan-14-25 08:30AM
Jan-06-25 08:30AM
Nov-12-24 08:30AM
Nov-08-24 04:03PM
Nov-07-24 05:55PM
04:05PM
Nov-06-24 07:37AM
Oct-31-24 10:01AM
Oct-29-24 08:30AM
Oct-22-24 08:30AM
Oct-21-24 08:30AM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Sep-25-24 08:30AM
Sep-09-24 05:28AM
Aug-19-24 03:27AM
Aug-06-24 07:00PM
04:15PM
04:05PM
Jul-23-24 08:30AM
Jul-12-24 02:46AM
Jul-09-24 09:35AM
Jun-20-24 08:30AM
May-17-24 02:33AM
May-08-24 02:54PM
04:03AM
May-07-24 09:56PM
06:18PM
04:08PM
May-03-24 10:12AM
06:41AM
Apr-30-24 08:30AM
Apr-25-24 10:02AM
Mar-13-24 09:16AM
Mar-12-24 05:52PM
05:30PM
04:05PM
Feb-27-24 08:30AM
Feb-15-24 10:00AM
Feb-13-24 09:55AM
Nov-27-23 08:30AM
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SHELTON JERRELL President, CEO Apr 21 '26 Option Exercise 1.87 104,007 194,493 1,230,614 Apr 23 08:00 PM SHELTON JERRELL President, CEO Apr 06 '26 Option Exercise 1.87 50,000 93,500 1,126,607 Apr 08 06:32 PM STEFANOVICH ROBERT Chief Financial Officer Mar 23 '26 Sale 8.18 1,094 8,949 279,277 Mar 25 08:01 PM SHELTON JERRELL President, CEO Mar 23 '26 Option Exercise 1.87 25,000 46,750 1,076,607 Mar 25 08:00 PM SHELTON JERRELL President, CEO Mar 23 '26 Sale 8.18 2,894 23,673 1,051,607 Mar 25 08:00 PM Sawicki Mark W Chief Scientific Officer Mar 23 '26 Sale 8.18 1,341 10,969 102,356 Mar 25 08:00 PM ZECCHINI EDWARD J See Remarks Mar 16 '26 Sale 8.00 2,014 16,112 109,719 Mar 17 08:01 PM SHELTON JERRELL President, CEO Mar 16 '26 Sale 8.00 7,918 63,344 1,054,501 Mar 17 08:00 PM Sawicki Mark W Chief Scientific Officer Mar 16 '26 Sale 8.00 3,235 25,880 103,697 Mar 17 08:00 PM STEFANOVICH ROBERT Chief Financial Officer Mar 12 '26 Option Exercise 1.87 87,188 163,042 294,401 Mar 16 09:35 PM STEFANOVICH ROBERT Chief Financial Officer Mar 12 '26 Sale 7.76 38,700 300,386 255,701 Mar 16 09:35 PM STEFANOVICH ROBERT Chief Financial Officer Mar 16 '26 Sale 8.00 2,743 21,944 280,371 Mar 16 09:35 PM ROBERT S. STEFANOVICH Officer Mar 12 '26 Proposed Sale 7.76 38,700 300,386 Mar 12 04:17 PM Mandalam Ramkumar Director Dec 10 '25 Sale 9.99 11,570 115,540 80,758 Dec 12 05:30 PM RAMKUMAR MANDALAM Director Dec 10 '25 Proposed Sale 9.99 11,570 115,540 Dec 10 04:10 PM Hariri Robert J Director Sep 11 '25 Option Exercise 2.66 50,000 133,000 76,275 Sep 12 05:30 PM Hariri Robert J Director Sep 11 '25 Sale 9.71 25,000 242,738 51,275 Sep 12 05:30 PM ROBERT HARIRI Director Sep 11 '25 Proposed Sale 9.71 25,000 242,738 Sep 11 04:29 PM Hariri Robert J Director Aug 22 '25 Sale 8.60 5,000 43,000 26,275 Aug 29 06:46 PM STEFANOVICH ROBERT Chief Financial Officer Aug 19 '25 Option Exercise 3.07 26,164 80,323 216,513 Aug 21 05:00 PM STEFANOVICH ROBERT Chief Financial Officer Aug 19 '25 Sale 8.67 9,300 80,618 207,213 Aug 21 05:00 PM ROBERT S. STEFANOVICH Officer Aug 19 '25 Proposed Sale 8.67 9,300 80,618 Aug 19 04:40 PM SHELTON JERRELL President, CEO Aug 13 '25 Option Exercise 5.00 25,000 125,000 1,062,419 Aug 15 05:00 PM SHELTON JERRELL President, CEO Jul 31 '25 Option Exercise 5.00 25,000 125,000 1,037,419 Aug 04 06:00 PM SHELTON JERRELL President, CEO Jul 24 '25 Option Exercise 5.00 25,000 125,000 1,012,419 Jul 28 05:04 PM Mandalam Ramkumar Director Jul 22 '25 Option Exercise 3.07 60,000 184,200 133,056 Jul 24 05:00 PM Mandalam Ramkumar Director Jul 22 '25 Sale 7.24 40,728 294,899 92,328 Jul 24 05:00 PM SHELTON JERRELL President, CEO Jul 18 '25 Option Exercise 5.00 25,000 125,000 987,419 Jul 22 04:52 PM RAMKUMAR MANDALAM Director Jul 22 '25 Proposed Sale 6.71 40,728 273,285 Jul 22 04:10 PM SHELTON JERRELL President, CEO Jul 08 '25 Option Exercise 5.00 25,000 125,000 962,419 Jul 10 05:00 PM SHELTON JERRELL President, CEO Jun 25 '25 Option Exercise 5.00 25,000 125,000 937,419 Jun 26 08:00 PM SHELTON JERRELL President, CEO Jun 24 '25 Option Exercise 5.00 16,344 81,720 928,763 Jun 26 08:00 PM SHELTON JERRELL President, CEO Jun 24 '25 Sale 7.06 16,344 115,366 912,419 Jun 26 08:00 PM Mandalam Ramkumar Director Jun 24 '25 Option Exercise 3.07 20,000 61,400 86,377 Jun 26 08:00 PM Mandalam Ramkumar Director Jun 24 '25 Sale 7.01 13,321 93,447 73,056 Jun 26 08:00 PM RAMKUMAR MANDALAM Director Jun 24 '25 Proposed Sale 6.56 13,321 87,386 Jun 24 04:09 PM SHELTON JERRELL President, CEO Jun 17 '25 Option Exercise 5.00 201,304 1,006,520 1,063,723 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 18 '25 Option Exercise 5.00 119,281 596,405 1,031,700 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 20 '25 Option Exercise 5.00 69,135 345,675 981,554 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 17 '25 Sale 6.81 151,304 1,029,715 912,419 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 18 '25 Sale 6.81 119,281 812,542 912,419 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 20 '25 Sale 6.47 69,135 447,525 912,419 Jun 20 08:15 PM JERRELL W SHELTON Director Jun 17 '25 Proposed Sale 6.93 356,064 2,467,524 Jun 17 04:14 PM Mandalam Ramkumar Director Jun 11 '25 Sale 7.06 8,193 57,816 68,896 Jun 13 07:00 PM Mandalam Ramkumar Director Jun 12 '25 Sale 7.01 1,895 13,286 67,001 Jun 13 07:00 PM Mandalam Ramkumar Director Jun 13 '25 Sale 6.80 624 4,246 66,377 Jun 13 07:00 PM RAMKUMAR MANDALAM Director Jun 13 '25 Proposed Sale 6.80 624 4,246 Jun 13 04:12 PM RAMKUMAR MANDALAM Director Jun 12 '25 Proposed Sale 7.01 1,895 13,286 Jun 12 04:18 PM RAMKUMAR MANDALAM Director Jun 11 '25 Proposed Sale 7.01 8,193 57,463 Jun 11 04:21 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 10 '25 Option Exercise 3.07 75,000 230,250 141,911 Jun 10 07:28 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 10 '25 Sale 6.84 51,500 352,518 90,411 Jun 10 07:28 PM Mandalam Ramkumar Director Jun 09 '25 Sale 7.06 5,622 39,673 77,089 Jun 10 07:25 PM EDWARD ZECCHINI Officer Jun 10 '25 Proposed Sale 6.84 51,500 352,512 Jun 10 04:29 PM RAMKUMAR MANDALAM Director Jun 09 '25 Proposed Sale 7.06 5,622 39,673 Jun 09 05:33 PM SHELTON JERRELL President, CEO Jun 04 '25 Option Exercise 5.00 50,000 250,000 862,419 Jun 06 02:21 PM Hariri Robert J Director May 28 '25 Sale 6.10 12,500 76,250 8,061 May 30 07:00 PM